UBS Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)
Go back to UBS Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)| (NASDAQ: MDGL) | Delayed: 524.87 +17.31 (3.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $507.56 | 52 Week High | $18.24 | |||
| Open | $509.16 | 52 Week Low | $6.60 | |||
| Day High | $527.22 | P/E | N/A | |||
| Day Low | $506.85 | EPS | $0.00 | |||
| Volume | 307,442 | |||||

